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Nickel compounds are well established by epidemiologic studies as human carcinogens. Although the carcinogenicity of nickel compounds has
been studied in experimental animals and in a variety of cultured mammalian cells, there are only sporadic reports of nickel-induced transformation
of human cells. In attempts to study the mechanisms of nickel-induced carcinogenesis in human cells, an immortalized human osteoblastic cell line
(HOS) that could not grow in soft agar or form tumors in athymic nude mouse was repeatedly treated with a water-soluble nickel compound (NiCI2)
or a less water-soluble nickel compound crystalline (NiS). After three rounds of NiS treatments, there was an increase in anchorage-independent (Al)
colony formation. This was not found in untreated or NiCI2-treated cells. Ten Al colonies obtained from NiS-treated cells were isolated. All of these
clones showed changes in cell morphology, including the appearance of uniform polygon shape, growth in multilayers, and heavy staining with
Giemsa. Most of these clones were retested for their ability to grow in soft agar and showed growth efficiencies of 5 to 50%. It has been shown by
other investigators that aggregate growth is well correlated with tumorigenic potential in viral or chemical transformants of HOS cells. Four of seven
tested NiS-transformed clones were able to form large aggregates compared to their untransformed counterparts, and continued to proliferate in
aggregate form when they were plated on 0.9% agar. Current investigations focus on the molecular and genetic changes induced by nickel com-
pounds in these human cells. - Environ Health Perspect 102(Suppl 3):289-292 (1994).
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Introduction
The inhalation of nickel compounds
leads to the formation oflung, sinonasal,
and laryngeal carcinomas in nickel refin-
ery workers (1,2). Nickel compounds are
also carcinogenic in experimental animals
(3). Inhalation is not the only adminis-
tration route for tumor induction by
nickel compounds. When particulate
nickel was administered to animals
intratesticularly, intramuscularly, and
intrarenally, it caused tumors at these
injection sites (4,5). In addition to
tumor induction in whole animals, nickel
compounds also induced morphologic
and neoplastic transformation in various
rodent cell systems such as Syrian ham-
ster embryo (SHE) cells (6), C3H/-
1OT1/2 mouse embryo fibroblasts (7),
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and Chinese hamster embryo (CHE)
cells (8). In spite oftheir potent carcino-
genicity, nickel compounds are not effec-
tive in inducing gene mutations in most
mammalian and bacterial cell systems,
but do cause DNA strand breaks (9),
DNA-protein cross-links (9-11), and
chromosomal aberrations (12,13). In
studies of nickel-induced chromosomal
aberrations it was shown that nickel pref-
erentially damages heterochromatin (14).
While the carcinogenicity of nickel
compounds has been extensively studied
in experimental animals and in a variety
of cultured mammalian cells, there are
only sporadic reports of nickel carcino-
genesis in cultured human cells.
Recently, Kumar and collaborators have
successfully induced neoplastic transfor-
mation of the immortal human
osteoblastic cell line (HOS) by treatment
with the water-soluble nickel compound
nickel sulfate (NiSO4) (15). However,
the most potent carcinogenic nickel com-
pounds are the water-insoluble particu-
late nickel compounds such as crystalline
nickel subsulfide and crystalline nickel
sulfide (4,16,17). Water-soluble nickel
compounds usually fail to produce
tumors in experimental animals (17). In
the present study, we utilized an immor-
tal, nontumorigenic HOS cell line to
study the capability of particulate nickel
sulfide to induce transformation and
compared the activity of a particulate
compound with water-soluble nickel
chloride.
Materials and Methods
Chemicals
Nickel chloride (NiCl2) and crystalline NiS
were purchased from Alfa Inorganics
(Danvers, MA). NiS was ground and
passed through a 5-pm screen, then steril-
ized by washing with acetone. Suspensions
ofparticulate nickel were prepared in tissue
culture media by agitation in a bath-type
sonicator. Measured volumes of the sus-
pension were applied to the cells and gently
mixed into the media in a tissue-culture
flask.
CellCulture andTransormation
Protocols
The HOS TE 85, Clone F-5 cell line was
obtained from American Type Culture
Colletion (Rockville, MD) and grown in
plastic flasks (Corning Glass Company,
Corning, NY) in minum esential medium
a-(MEM) containing 10% fetal bovine
serum. For transformation, 1 x 106 HOS
cells were plated in 75 cm2 plastic flasks
and treated 24 hr later with 10 mg/ml NiS
or 100 mM NiCI2 for 24 hr. The nickel
containing medium was removed and the
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Figure 1. Morphology ofHOS and NiStransformed clones. Control HOS cells (A)and one ofthe NiS-transformed cells,
HOS1-3/SA-8, (B growing at lowcell densify. Note thatthe NiS transformed clone has lostthe epithelial like morphol-
ogy and now grows in clusters. Cell-growth patterns at confluence are shown for control HOS cells (C and NiS trans-
formed-clones, HOS1-3/SA-1 (D), HOS1-3/SA-3 (EL, and HOS1-3/SA-4 (F). Note the morphologic alterations in the
nickel transformed clones as evidenced bygrowth in multiple layers.
cells were rinsed three times with serum-
free medium. Fresh a-MEM was added and
the cells were allowed to grow to conflu-
ence. The cultures were split 1:10 and were
then treated for a second time with 2
mg/ml NiS or 100 mM NiCl2 for 24 hr.
They were again allowed to recover in fresh
medium until the cultures reached 100%
confluence. After a second subculture the
cells were treated for a third time with 2
mg/ml NiS or 100 mM NiCl2 for 24 hr,
and were allowed to proliferate. After the
three separate nickel treatments, the cells
were plated in soft agar and ten individual
colonies were cloned and expanded into
mass culture (HOS1-3/SA-N).
AssayforAnchorage Independence
Growth
In the assay for anchorage-independence
growth, 1 x 103 or 1 x I05 cells were
plated in 5 ml 0.3% agarose in a-MEM,
10% fetal bovine serum overlaid onto a
solid layer of 0.6% agarose in a-MEM
with 10% fetal bovine serum. The cul-
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Figure 2. Aggregate proliferation of normal HOS and
nickel transformed HOS clones. Aggregate growth was
quantitated as described in Materials and Methods. The
results are expressed asthe mean ± SD, n=3.
tures were maintained for 2 weeks and
colonies larger than 0.1 mm (small) or
>0.5 mm (large) were counted. The plat-
ing efficiency in agar was determined by
dividing the number of colonies obtained
per plate by the number ofcells plated.
AggrgationAssay
A 2-ml suspension ofcells (1 x 105/ml) in
a-MEM containing 10% fetal bovine
serum was plated on top of 2 mL of0.9%
agarose in a-MEM, 10% fetal bovine
serum in each well of a six-well tissue-cul-
ture plate. The plates were incubated in
5% CO2, 95% air, at 370C for 3 days. On
the third day ofculture, the cell suspension
was collected and washed three times with
serum free medium. The collected cell
aggregates were resuspended into single cell
suspensions in 0.025% trypsin and 0.02%
EDTA for 5 min. The disbanded aggre-
gates were resuspended in an appropriate
volume and the cell numbers were deter-
mined.
Results
After repeated treatments with insoluble
nickel compounds over a period of one
month, no alterations in morphology and
growth pattern were observed in the cul-
Table 1. Plating efficiency of NiS treated HOS cells in softagar.a
Clone PE in softagar % Colony size
HOSTE-85
HOS1-3/SA-1 9.6 Small
HOS1-3/SA-2 5.8 Small
HOS1-3/SA-3 17.8 Small
HOS1-3/SA-4 50.2 Large
HOS1-3/SA-5 26.0 Large
HOS1-3/SA-6 5.0 Large
HOS1-3/SA-7 30.4 Large
HOS1-3/SA-8 32.8 Large
al x 104 cells were plated in dishes containing 0.3% agar, then incubated for 2 weeks. Colonies 0.1 mm but <0.5 mm
(small) orcolonies>0.5 mm(large)werecounted, andthe plating efficiencies in softagarweredetermined bydividingthe
numberofcolonies obtained perplate bythe numberofcells plated.
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tured HOS cells. However, when these
cells were plated in soft agar, NiS-treated
cells had a plating efficiency ofabout 0.1%,
whereas the control and NiCl2-treated cells
did not form any true colonies (larger than
0.1 mm in soft agar). Ten of the NiS
treated colonies were cloned from the soft
agar and expanded to mass culture (HOS1-
3/SA-1, HOS1-3/SA-2, etc.). All these
clones exhibited altered morphology,
including dark staining with Giemsa and
the acquisition ofa uniform polygon shape
in contrast to the flat epithelial like mor-
phology of their parental cells (Figure 1).
These clones also exhibited an alteration in
their growth patterns, such that they grew
in multilayers at high density and in aggre-
gates at low cell density, whereas the
parental cells grew in a sporadic manner
(Figure 1). The eight tested clones exhib-
ited high plating efficiency (5 to 50%)
when regrown in soft agar, and most of
them formed large colonies (>0.5 mm)
(Table 1). When the nickel-treated and
parental cells were plated in liquid
medium above a 0.9% agar layer, cell
attachment was prevented. Cell aggregates
appeared within 24 hr after seeding. Four
of the five clones that formed large
colonies in soft agar also formed large cell
aggregates, and these cell populations pro-
liferated in the aggregate form over a 3 day
period (Figure 2).
Discussion
Neoplastic transformation of cells in cul-
ture is one of the few systems that can be
used to study the mechanisms of human
carcinogenesis. To date most of the neo-
plastic transformation studies have been
carried out using rodent cells such as
Syrian hamster embryo cells and
C3H/1OT1/2 cells. Although we do not
understand the details, it is known that
significant differences exist between rodent
and human cells in their responses to car-
cinogens. In general, cultured human cells
are more resistant than rodent cells to neo-
plastic transformation by carcinogens.
We have selected an immortal non-
tumorigenic human osteoblastic cell line,
HOS TE 85 to study neoplastic transfor-
mation by nickel compounds. The HOS
TE 85 cells originated from a human
osteosarcoma (18). HOS TE 85 are
immortal cells, which grow at high cell
density, form minute colonies (less than
20 cells per colony) ofless than 0.1 mm in
soft agar, exhibit very low plating effi-
ciency, and do not induce tumors when
injected into nude mice. It is assumed that
HOS TE 85 was epithelial in origin. This
cell line has been used in transformation
studies because it is easily transformed by
viruses and other chemical carcinogens
(19,20). Our results show that after NiS
treatment HOS cells acquired Al growth
and morphologic changes that were similar
to those of HOS cells treated with NiSO4
and hexavalent chromates (15,22). Some
isolated clones even exhibited growth in
liquid medium. These results indicated
that crystalline NiS can induced transfor-
mation ofthe HOS cells.
Previous studies have shown that there
is a striking difference in carcinogenic
potency between crystalline and water sol-
uble nickel compounds. This may be the
result ofdifferences in the uptake ofthese
two types of nickel compounds. It was
found that crystalline nickel compounds
such as NiS and Ni3S2 were taken up by
cells through phagocytosis (23,24)
whereas water-soluble nickel salts passed
through cell membrane ion channels or
were taken up by cells along with other
molecules such as proteins and amino
acids. Once nickel ions enter cells they
bind to intracellular ligands, i.e., proteins.
Since nickel ions have high binding con-
stants for certain amino acids, the binding
to protein may reduce the accessibility of
these ions to the nuclei. In the case of
crystalline nickel sulfide, phagocytized
particulate nickel dissolves in the cellular
vacuoles because of the acidic environ-
ment. Relatively high concentrations of
these nickel ions were distributed to all
cellular compartments including nuclei.
The intracellular delivery of a significant
nickel ion concentration may be one rea-
son why crystalline nickel sulfide com-
pounds are more carcinogenic than the
water-soluble compounds. In our study,
human HOS cells were treated repeatedly
in culture with insoluble nickel com-
pounds. Under these conditions, only
crystalline nickel but not NiCl2, produced
transformation of the HOS cells.
Extensive treatment of HOS cells with
NiSO4 for long periods has been shown to
induce anchorage-independent growth
(22). The present study did not confirm
this result, perhaps because the treatment
time was insufficient. Future studies will
focus on the genetic changes associated
with nickel-induced neoplastic transfor-
mation ofhuman cells.
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